Pivotal Study to Evaluate Safety and Immunogenicity of a Live-Attenuated Chikungunya Virus Vaccine Candidate in Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

4,128

Participants

Timeline

Start Date

September 17, 2020

Primary Completion Date

May 19, 2021

Study Completion Date

October 15, 2021

Conditions
Chikungunya Virus Infection
Interventions
BIOLOGICAL

VLA1553

Single intramuscular vaccination on Day 1 with VLA1553, a lyophilized live-attenuated Chikungunya vaccine candidate; 1x10E4 TCID50 per dose

BIOLOGICAL

Placebo

Single intramuscular vaccination on Day 1 with Phosphate-Buffered Saline (PBS) as placebo

Trial Locations (44)

13760

Meridian Clinical Research, Endwell

14609

Rochester Clinical Research, Rochester

23507

Alliance for Multispecialty Research (AMR), Norfolk

28403

ELITE Research Network (ELITE), Wilmington

28557

Lucas Research, Morehead City

29621

Synexus - Anderson, Anderson

Vitalink Research - Anderson, Anderson

32081

Jacksonville Center for Clinical Research, LTD dba St. Johns Center for Clinical Research, Ponte Vedra

32162

Synexus - The Villages, The Villages

32720

Accel Research Sites - DeLand, DeLand

32751

Meridien Research - Maitland, Maitland

32934

Accelerated Enrollment Solutions (AES), Melbourne

33009

ELITE Research Network (ELITE), Hallandale

33135

Suncoast Research Group, LLC, Miami

ELITE Research Network (ELITE), North Miami Beach

37920

Alliance for Multispecialty Research (AMR), Knoxville

40509

Alliance for Multispecialty Research (AMR), Lexington

45236

Accelerated Enrollment Solutions (AES), Cincinnati

60602

Accelerated Enrollment Solutions (AES), Chicago

61614

Accelerated Enrollment Solutions (AES), Peoria

64114

Alliance for Multispecialty Research (AMR), Kansas City

67042

Alliance for Multispecialty Research (AMR), El Dorado

67114

Alliance for Multispecialty Research (AMR), Newton

67207

Alliance for Multispecialty Research (AMR), Wichita

68134

Platinum Research Network (Platinum), Omaha

68144

Accelerated Enrollment Solutions (AES), Omaha

68803

Meridian Clinical Research - Grand Island, Grand Island

70119

AMR - New Orleans - Center for Clinical Research, New Orleans

72204

ELITE Research Network (ELITE), Little Rock

73112

ELITE Research Network (ELITE), Oklahoma City

75093

Research Your Health, LLC, Plano

77375

ELITE Research Network (ELITE), Tomball

77706

Tekton Research - Beaumont, Beaumont

78521

PanAmerican Clinical Research - US Headquarter, Brownsville

78613

Velocity Clinical Research - Austin, Cedar Park

83642

ELITE Research Network (ELITE), Meridian

84088

ELITE Research Network (ELITE), West Jordan

85020

Accelerated Enrollment Solutions (AES), Phoenix

85224

Accelerated Enrollment Solutions (AES), Chandler

85283

Alliance for Multispecialty Research (AMR), Tempe

89119

Alliance for Multispecialty Research (AMR), Las Vegas

91911

Velocity Clinical Research, Chula Vista, Chula Vista

92108

Accelerated Enrollment Solutions (AES), San Diego

97504

Velocity Clinical Research - Medford, Medford

All Listed Sponsors
lead

Valneva Austria GmbH

INDUSTRY

NCT04546724 - Pivotal Study to Evaluate Safety and Immunogenicity of a Live-Attenuated Chikungunya Virus Vaccine Candidate in Adults | Biotech Hunter | Biotech Hunter